Dapsone as a potential treatment for cutaneous Rosai-Dorfman disease with neutrophilic predominance.
Chan
Chih-Chieh
CC
Department of Dermatology, National Taiwan University Hospital, Taipei.
Chu
Chia-Yu
CY
D000284:Administration, Oral; D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage / Q000627:therapeutic use*; D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use*; D003937:Diagnosis, Differential; D005260:Female; D015618:Histiocytosis, Sinus / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D020556:Neutrophil Infiltration; D012782:Shoulder / Q000473:pathology; D012867:Skin / Q000473:pathology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003622:Dapsone